EV-TT Transfer Center

The Transfer Center for Extracellular Vesicles Theralytic Technologies (EV-TT) capitalizes on basic biological, pharmaceutical and chemical research to develop new technologies for the characterization and future therapeutic use of extracellular vesicles (EV). The main focus of the EV-TT Transfer Center lies i) on application-oriented transdisciplinary research, ii) in the transfer of research results, both in the education of students and in the economy, as well as iii) in the initiation of new joint research projects. The EV-TT Transfer Center deals with the simultaneous development of manufacturing and analytical methods for the establishment of EV-based therapeutics. Activities are centered on regenerative medicine with a specific attention towards supporting natural healing processes as well as drug delivery. From the combination of therapeutics production and a tailor-made analysis technique arise the new field of the theralytic technologies.

The EV-TT Transfer Center is a cooperation between the Paracelsus Medical University (PMU), the Paris Lodron University Salzburg (PLUS) and the University Hospital (SALK). As part of WISS 2025, the EV-TT Transfer Center is funded by Land Salzburg and by EFRE funds from the European Union.

Further information about IWB/ ERFE can be found on www.efre.gv.at.


Current Posts

Univ.-Prof. Dr. Eva Rohde interviewed by VJRegenMed

VJRegenMed - The Video Journal of Regenerative Medicine

Congratulations, paper accepted!

Publication in the International Journal of Molecular Sciences by Dr. André Cronemberger-Andrade, a.o. Univ.-Prof. Dr. Katharina Schallmoser, MSc and Univ.-Prof. Dr. Dirk Strunk

Congratulations, paper accepted!

Publication in Advanced Drug Delivery Reviews by Univ.-Prof. Dr. Dirk Strunk

Congratulations, paper accepted!

Publication in Theranostics by a.o. Univ.-Prof. Dr. Katharina Schallmoser, MSc and Univ.-Prof. Dr. Dirk Strunk.